You are invited to attend two panels, hosted by the Middlebury Consulting Group and the CCI, that are geared toward students interested in pursuing consulting professionally.
The first panel will consist of current students that interned last summer or will intern this summer at consulting firms such as Kaiser Associates, PwC, and Accenture. The second panel will consist of current students that have accepted full-time offers at consulting firms such as Analysis Group and Bain & Company.
A link to the new user-friendly system is also available via the DPS parking web page. The system manages everything from permit registration and student registration fees to payment of fines. Using hand-held devices, officers will issue tickets electronically. Registered permit holders will automatically receive an email notification about any violation related to their vehicle.
For more information about parking registration, please visit the parking web page or go/parking.
Got a goal? Goaloop it! Like YouTube is for videos and Amazon is for products, Goaloop is for goals.
Goaloop is a tech start-up based in Manhattan and they recently reached beta launch! Join them and become important members of their small, innovative team – which is growing. Goaloop helps you reach your goals and connects the world through goals. Got a goal? Goaloop it! State your goal on Goaloop, and people and resources come to you to help you achieve it. Connecting goals expands social circles and increases commercial opportunities. Connecting goals, we can achieve anything together!
The National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH) seeks highly-motivated applicants for scientific administrative openings as a Scientific Program Analyst in Bethesda, MD.
This is an exciting opportunity for recent graduates in the biological sciences to gain first-hand experience in and broad exposure to how cutting-edge medical research is supported. It is an ideal position for applicants seeking a two-year appointment prior to enrolling in graduate or professional school. The position supports the genomics research programs and consortia funded by NHGRI. The Scientific Program Analyst will carry out administrative duties and scientific analyses in support of Program Directors in the NHGRI Extramural Research Program, which awards grants to the academic and biotechnology communities to carry out basic and applied genomics research. Please see https://www.genome.gov/researchfunding/ for more information about NHGRI.
There are two RA positions open in Pediatric Oncology at Dana Farber. Dr. Birgit Knoechel writes, “The overarching goal of my lab and the Lohr lab is to study the biology of therapeutic resistance in cancer with a particular focus on genomic and epigenetic aberrations. We use single cell/low input genomics, epigenomics and other single cell technology to define dynamic changes in tumor model systems and primary patient samples with a disease focus on hematologic malignancies and sarcoma. We also use a wide variety of tools to study underlying mechanisms, which span the entire spectrum from biochemistry, functional perturbation to in vivo mouse models.”
Click on the titles to learn how to apply.
RA Epigenetics – The Dana-Farber Cancer Institute is looking for an exceptional candidate for a unique Research Associate position. This position affords the exciting opportunity to be part of a research effort at Dana-Farber Cancer Institute aiming to delineate epigenomic aberrations in cancer and discover novel therapeutic targets. The candidate will assist in the development of cancer models from primary human tumors and human cell lines that represent different cellular lineages and drug-resistant states. He/she will use modern next generation sequencing techniques to characterize the chromatin state of these tumors and modern functional perturbation techniques including lentiviral knockdown and CRISPR/Cas9 genome editing tools. He/she will test the model systems in immuno-compromised mice for their ability to form tumors and to test for drug responses. He/she will be part of a multi-disciplinary team that evaluates new technologies and approaches to discover and validate novel systemic cancer biology.
RA Genomics – Dana-Farber Cancer Institute is looking for an exceptional candidate for a unique Research Associate position. This position affords the exciting opportunity to be part of a research effort at Dana-Farber Cancer Institute aiming to delineate genomic aberrations in cancer biology and discover novel therapeutic targets. He/she will use modern next generation sequencing techniques to characterize genomic aberrations and modern functional perturbation techniques including CRISPR/Cas9 and other genome editing tools. He/she will use various model systems to test for drug responses and determine mechanisms of resistance to drugs, including novel immunotherapies. He/she will be part of a multi-disciplinary team that evaluates new technologies and approaches to discover and validate novel systemic cancer biology.
This position is brought to you by Annie Cowan ’18 – application deadline February 3rd:
Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, they provide compassionate and comprehensive care to patients of all ages; they conduct research that advances treatment; they educate tomorrow’s physician/researchers; they reach out to underserved members of their community; and they work with amazing partners, including other Harvard Medical School-affiliated hospitals.
The Clinical Research Coordinator works within the clinical research program and supports the research team in the overall conduct of clinical trials using Good Clinical Practice under the auspices of the Principal Investigator(s) and the DFCI Clinical Trials Office. The CRC will be responsible for the primary data collection and management of patient clinical information as it pertains to participation in clinical trials. Ensures timely collection of protocol related samples including shipment to outside entities as required. Maintains regulatory binders and ensures study compliance with all state, federal, and IRB requirements. May be responsible for IRB protocol submissions (amendments, continuing reviews, and minimal risk protocols). This individual may also screen patients for protocol eligibility, obtain informed consent, and register study participants to clinical trials. Some travel may be required